Z.M.D Diagnostics

Company Overview

Snapshot

Founded in August 2014 by Dr. Mark Gaides, Z.M.D Diagnostics operated with 1–10 employees. The company developed a patent-protected automated diagnosis system for early cancer detection. Z.M.D Diagnostics ceased operations in October 2020.

Business overview

Z.M.D Diagnostics specialized in developing an automated diagnosis system for the early detection of cancer by measuring the oncolytic activity of bacteria in the intestinal microflora. This system was designed to identify cancer long before tumor formation and predict recurrence in patients in remission by assessing immune system strength. Operating within the Health Tech & Life Sciences sector, specifically Digital Healthcare and Digital Medical Diagnostics, the company served hospitals and individual patients with both clinical and home-use designs.

Company Intelligence Q&A

What was Z.M.D Diagnostics' primary focus?

Z.M.D Diagnostics focused on developing an automated system for the early diagnosis of cancer by measuring the oncolytic activity of bacteria in the intestinal microflora.

When was Z.M.D Diagnostics founded?

Z.M.D Diagnostics was founded in August 2014.

Who was a key founder of Z.M.D Diagnostics?

Dr. Mark Gaides was a co-founder and CSO of Z.M.D Diagnostics.

What was the operational status of Z.M.D Diagnostics?

Z.M.D Diagnostics ceased to operate in October 2020.

Did Z.M.D Diagnostics hold any patents?

Yes, Z.M.D Diagnostics developed a patent-protected system for cancer diagnosis.